Trial Profile
Celecoxib as adjuant therapy in the treatment of OCD: a double blind randomized trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 28 Feb 2018
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Fluvoxamine
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from recruiting to completed.
- 19 Feb 2014 New trial record